Patents by Inventor Wade BENTON

Wade BENTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transitioning patients treated for pulmonary arterial hypertension to selexipag
    Patent number: 12419887
    Abstract: The present disclosure provides methods of transitioning a patient being treated for pulmonary arterial hypertension with a non-selexipag prostacyclin pathway agent (PPA) to selexipag.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: September 23, 2025
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Carol Zhao, Johanna Colvin Riesen, Gary Arnold Palmer, Michael Keating, Brian Hartline, Wade Benton, Camelia Dumitrescu, Mehul Bipinchandra Shah
  • TRANSITIONING PATIENTS TREATED FOR PULMONARY ARTERIAL HYPERTENSION TO SELEXIPAG
    Publication number: 20220257594
    Abstract: The present disclosure provides methods of transitioning a patient being treated for pulmonary arterial hypertension with a non-selexipag prostacyclin pathway agent (PPA) to selexipag.
    Type: Application
    Filed: May 20, 2020
    Publication date: August 18, 2022
    Inventors: Carol ZHAO, Johanna COLVIN RIESEN, Gary Arnold PALMER, Michael KEATING, Brian HARTLINE, Wade BENTON, Camelia DUMITRESCU, Mehul Bipinchandra SHAH